-
Samantha Hutten, PhD, Vice President of Translational Research at MJFF. “We are excited to apply C2N’s analytically validated biomarker tests widely used in the field of Alzheimer’s disease research..."
-
Funding allows for expansion of labs, teams, and additional species candidates for de-extinction
-
Vistagen CEO Shawn Singh; The Goldie Hawn Foundation Founder Goldie Hawn; and MindUP students to ring the Nasdaq Closing Bell on October 10, 2024Vistagen and The Goldie Hawn Foundation join forces to raise awareness around the roles of mindfulness and pioneering neuroscience in mental health
-
Additionally, Ivanti plans to leverage insights from its comprehensive greenhouse gas footprint assessment to reduce its environmental impact.
-
Each Prize Winner to Receive $750,000 Over Three Years
-
-- Company creates 10 academic scholarships supporting siblings in Rett syndrome community pursuing dreams in higher education-- Applications now available through January 31, 2024, for the 2024-2025 academic year
-
Mitochon Pharmaceuticals today is pleased to announce the receipt of a $500,000 grant in conjunction with the University of Kentucky for “Advancement of Drugs for the Treatment of Repeated Mild Traumatic Brain Injury (mTBI)” through a joint funded program by an Alzheimer’s Disease group, BrightFocus Foundation and a military focused foundation, Medical Technology Enterprise Consortium (MTEC). The money will be used to advance Mitochon’s second compound MP-201 through IND enabling studies and pro
-
More than 200 global organizations have now joined The Climate Pledge and are pursuing ambitious carbon-reduction activities, including operational changes in the race to fight climate changeTogether, Pledge signatories generate over $1.8 trillion in global annual revenues and are expected to collectively mitigate 1.98 billion metric tons of carbon emissions annually by 2040 from a 2020 baseline
-
Company introduces next-gen data application to track flow of recyclable mixed plastics, paper, metals, and other scrap through the recycling value chain
-
Study will use ‘miniature brains’ cultivated from stem cells to study protein mutations